Much of our current understanding of measles has come from experiments in non-human primates. In 1911, Goldberger and Anderson showed that macaques inoculated with filtered secretions from measles patients developed measles, thus demonstrating that the causative agent of this disease was a virus. Since then, different monkey species have been used for experimental measles virus infections. Moreover, infection studies in macaques demonstrated that serial passage of the virus in vivo and in vitro resulted in virus attenuation, providing the basis for all current live-attenuated measles vaccines. This chapter will review the macaque model for measles, with a focus on vaccination and immunopathogenesis studies conducted over the last 15 years. In addition, recent data are highlighted demonstrating that the application of a recombinant measles virus strain expressing enhanced green fluorescent protein dramatically increased the sensitivity of virus detection, both in living and sacrificed animals, allowing new approaches to old questions on measles vaccination and pathogenesis.
Chapter PDF
References
Albrecht P, Lorenz D, Klutch MJ, Vickers JH, Ennis FA (1980) Fatal measles infection in marmosets pathogenesis and prophylaxis. Infect Immun 27:969–978
Albrecht P, Lorenz D, Klutch MJ (1981) Encephalitogenicity of measles virus in marmosets. Infect Immun 34:581–587
Anderson JF, Goldberger J (1911) Experimental measles in the monkey: a supplemental note. Public Health Reports 26:887–895
Auwaerter PG, Rota PA, Elkins WR, Adams RJ, DeLozier T, Shi Y, Bellini WJ, Murphy BR, Griffin DE (1999) Measles virus infection in rhesus macaques: altered immune responses and comparison of the virulence of six different virus strains. J Infect Dis 180:950–958
Bankamp B, Hodge G, McChesney MB, Bellini WJ, Rota PA (2008) Genetic changes that affect the virulence of measles virus in a rhesus macaque model. Virology 373:39–50
Blake FG, Trask Jr JD (1921a) Studies on measles. I. Susceptibility of monkeys to the virus of measles. J Exp Med 33:385–412
Blake FG, Trask Jr JD (1921b) Studies on measles. II. Symptomatology and pathology in monkeys experimentally infected. J Exp Med 33:413–422
Blake FG, Trask Jr JD (1921c) Studies on measles. III. Acquired immunity following experimental measles. J Exp Med 33:621–626
Burnet FM (1968) Measles as an index of immunological function. Lancet 292:610–613
Buynak EB, Peck HM, Creamer AA, Goldner H, Hilleman MR (1962) Differentiation of virulent from avirulent measles strains. Am J Dis Child 103:290–303
Chen RT, Markowitz LE, Albrecht P, Stewart JA, Mofenson LM, Preblud SR, Orenstein WA (1990) Measles antibody: reevaluation of protective titers. J Infect Dis 162:1036–1042
Condack C, Grivel J-C, Devaux P, Margolis L, Cattaneo R (2007) Measles virus vaccine attenuation: suboptimal infection of lymphatic tissue and tropism alteration. J Infect Dis 196:541–549
Cutts FT, Clements CJ, Bennett JV (1997) Alternative routes of measles immunization: a review. Biologicals 25:323–338
De Swart RL, Kuiken T, Timmerman HH, Van Amerongen G, van den Hoogen BG, Vos HW, Neijens HJ, Andeweg AC, Osterhaus ADME (2002) Immunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersen-sitivity to subsequent RSV infection. J Virol 76:11561–11569
De Swart RL, Kuiken T, Fernandez de Castro J, Papania MJ, Valdespino JL, Minor P, Witham C, Yüksel S, Vos HW, Van Amerongen G, Osterhaus ADME (2006) Aerosol measles vaccination in macaques: preclinical studies of immune responses and safety. Vaccine 24:6424–6436
De Swart RL, LiCalsi C, Quirk AV, Van Amerongen G, Nodelman V, Alcock R, Yüksel S, Ward GH, Hardy JG, Vos HW, Witham CL, Grainger CI, Kuiken T, Greenspan BJ, Gard TG, Osterhaus ADME (2007a) Measles vaccination of macaques by dry powder inhalation. Vaccine 25:1183–1190
De Swart RL, Ludlow M, De Witte L, Yanagi Y, Van Amerongen G, McQuaid S, Yüksel S, Geijtenbeek TBH, Duprex WP, Osterhaus ADME (2007b) Predominant infection of CD150 + lymphocytes and dendritic cells during measles virus infection of macaques. PLoS Pathog 3: e178
De Swart RL, van den Hoogen BG, Kuiken T, Herfst S, Van Amerongen G, Yüksel S, Sprong L, Osterhaus ADME (2007c) Immunization of macaques with formalin-inactivated human metapneumovirus induces hypersensitivity to hMPV infection. Vaccine 25:8518–8528
Dilraj A, Cutts FT, Fernandez de Castro J, Wheeler JG, Brown D, Roth C, Coovadia HM, Bennett JV (2000) Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial. Lancet 355:798–803
El Mubarak HS, Yüksel S, Van Amerongen G, Mukhtar MM, De Swart RL, Osterhaus ADME (2007) Infection of cynomolgus macaques ( Macaca fascicularis ) and rhesus macaques ( Macaca mulatta ) with different wild-type measles viruses. J Gen Virol 88:2028–2034
Enders JF, Peebles TC (1954) Propagation in tissue cultures of cytophatic agents from patients with measles. Proc Soc Exp Biol Med 86:277–286
Enders JF, Katz SL, Milovanovic M V, Holloway A (1960) Studies on an attenuated measles-virus vaccine I. Development and preparation of the vaccine: techniques for assay of effects of vaccination. N Engl J Med 263:153–159
Finkeldey W (1931) Über Riesenzellbefunde in den Gaumenmandeln, zugleich ein Beitrag zur Histopathologie der Mandelveränderungen im Maserninkubationsstadium. Virchows Arch 281:323–329
Foege WH, Leland OS, Mollohan CS, Fulginiti VA, Henderson DA, Kempe CH (1965) Inactivated measles-virus vaccine. Public Health Reports 80:60–64
Fulginiti VA, Eller JJ, Downte AW, Kempe CH (1967) Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines. JAMA 202:1075–1080
Fulginiti VA, Eller JJ, Sieber OF, Joyner JW, Minamitani M, Meiklejohn G (1969) Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. Am J Epidemiol 89:435–448
Goldberger J, Anderson JF (1911) An experimental demonstration of the presence of the virus of measles in the mixed buccal and nasal secretions. J Am Med Assoc 57:476–478
Griffin DE, Ward BJ, Esolen LM (1994) Pathogenesis of measles virus infection: an hypothesis for altered immune responses. J Infect Dis 170 [Suppl. 1]:S24–S31
Hall WC, Kovatch RM, Herman PH, Fox JG (1971) Pathology of measles in rhesus monkeys. Vet Pathol 8:307–319
Hashimoto K, Ono N, Tatsuo H, Minagawa H, Takeda M, Takeuchi K, Yanagi Y (2002) SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein. J Virol 76:6743–6749
Hicks JT, Sullivan JL, Albrecht P (1977) Immune responses during measles infection in immuno-suppressed rhesus monkeys. J Immunol 119:1452–1456
Hilleman MR, Stokes J, Buynak EB, Reilly CM, Hampil B (1962) Immunogenic response to killed measles-virus vaccine. Am J Dis Child 103:274–281
Hime JM, Keymer IF (1975) Measles in recently imported colobus monkeys ( Colobus guereza). Vet Rec 97:392
Hirsch RL, Griffin DE, Johnson RT, Cooper SJ, Lindo de Soriano I, Roedenbeck S, Vaisberg A (1984) Cellular immune responses during complicated and uncomplicated measles virus infections of man. Clin Immunol Immunopathol 31:1–12
Hoffman SJ, Polack FP, Hauer DA, Griffin DE (2003a) Measles virus infection of rhesus macaques affects neutrophil expression of IL-12 and IL-10. Viral Immunol 16:369–379
Hoffman SJ, Polack FP, Hauer DA, Singh M, Billeter MA, Adams RJ, Griffin DE (2003b) Vaccination of rhesus macaques with a recombinant measles virus expressing interleukin-12 alters humoral and cellular immune responses. J Infect Dis 188:1553–1561
Kapikian AZ, Mitchell RH, Chanock RM, Shvedoff RA, Stewart CE (1969) An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am J Epidemiol 89: 405–421
Kim HW, Canchola JG, Brandt CD, Pyles G, Chanock RM, Jensen K, Parrott RH (1969) Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol 89:422–434
Kobune F, Sakata H, Sugiura A (1990) Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus. J Virol 64:700–705
Kobune F, Takahashi H, Terao K, Ohkawa T, Ami Y, Suzaki Y, Nagata N, Sakata H, Yamanouchi K, Kai C (1996) Nonhuman primate models of measles. Lab Anim Sci 46:315–320
Levy BM, Mirkovic RR (1971) An epizootic of measles in a marmoset colony. Lab Anim Sci 21:33–39
LiCalsi C, Maniaci MJ, Christensen T, Phillips E, Ward GH, Witham C (2001) A powder formulation of measles vaccine for aerosol delivery. Vaccine 19:2629–2636
MacArthur JA, Mann PG, Oreffo V, Scott GBD (1979) Measles in monkeys: an epidemiological study. J Hyg 83:207–212
Marshall E, Enserink M (2004) Caution urged on SARS vaccines. Science 303:944–946
McChesney MB, Fujinami RS, Lerche NW, Marx PA, Oldstone MBA (1989) Virus-induced immunosuppression: infection of peripheral blood mononuclear cells and suppression of immunoglobulin synthesis during natural measles virus infection of rhesus monkeys. J Infect Dis 159:757–760
McChesney MB, Miller CJ, Rota PA, Zhu Y, Antipa L, Lerche NW, Ahmed R, Bellini WJ (1997) Experimental measles I. Pathogenesis in the normal and the immunized host. Virology 233:74–84
Meyer HM, Brooks BE, Douglas RD, Rogers NG (1962) Ecology in measles in monkeys. Am J Dis Child 103:138–143
Mongkolsapaya J, Jaye A, Callan MFC, Magnusen AF, McMichael AJ, Whittle HC (1999) Antigen-specific expansion of cytotoxic T lymphocytes in acute measles virus infection. J Virol 73:67–71
Moss WJ, Ryon JJ, Monze M, Griffin DE (2002) Differential regulation of interleukin (IL)-4, IL-5, and IL-10 during measles in Zambian children. J Infect Dis 186:879–887
Nii S, Kamahora J, Mori Y, Takahashi M, Nishimura S, Okuno Y (1964a) Experimental pathology of measles in monkeys. Biken J 6:271–297
Nii S, Kamahora J, Okuno Y, Nishimura S, Kato S, Aoyama Y (1964b) Studies on the biological effects of live attenuated measles vaccines in monkeys. Biken J 7:65–69
Norrby E, Carlstrom G, Lagercrantz R, Gard S (1964) Measles vaccination II. Antibody titers 8 to 9 months after vaccination with an inactivated vaccine. Acta Paediat 53:533–540
Norrby E, Enders-Ruckle G, Ter Meulen V (1975) Differences in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus. J Infect Dis 132:262–269
Okada H, Kobune F, Sato TA, Kohama T, Takeuchi Y, Abe T, Takayama N, Tsuchiya T, Tashiro M (2000) Extensive lymphopenia due to apoptosis of uninfected lymphocytes in acute measles patients. Arch Virol 145:905–920
Pahar B, Li J, McChesney MB (2005) Detection of T cell memory to measles virus in experimentally infected rhesus macaques by cytokine flow cytometry. J Immunol Methods 304:174–183
Pan CH, Valsamakis A, Colella T, Nair N, Adams RJ, Polack FP, Greer CE, Perri S, Polo JM, Griffin DE (2005) Modulation of disease, T cell responses, and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles. Proc Natl Acad Sci U S A 102:11581–11588
Pasetti MF, Resendiz-Albor A, Ramirez K, Stout R, Papania M, Adams RJ, Polack FP, Ward BJ, Burt D, Chabot S, Ulmer J, Barry EM, Levine MM (2007) Heterologous prime-boost strategy to immunize very young infants against measles: pre-clinical studies in rhesus macaques. Clin Pharmacol Ther 82:672–685
Peebles TC, McCarthy K, Enders JF, Holloway A (1957) Behavior of monkeys after inoculation of virus derived from patients with measles and propagated in tissue culture together with observations on spontaneous infections of these animals by an agent exhibiting similar anti-genic properties. J Immunol 78:63–74
Permar SR, Klumpp SA, Mansfield KG, Kim WK, Gorgone DA, Lifton MA, Williams KC, Schmitz JE, Reimann KA, Axthelm MK, Polack FP, Griffin DE, Letvin NL (2003) Role of CD8 + lymphocytes in control and clearance of measles virus infection of rhesus monkeys. J Virol 77:4396–4400
Permar SR, Klumpp SA, Mansfield KG, Carville AA, Gorgone DA, Lifton MA, Schmitz JE, Reimann KA, Polack FP, Griffin DE, Letvin NL (2004) Limited contribution of humoral immunity to the clearance of measles viremia in rhesus monkeys. J Infect Dis 190:998–1005
Polack FP, Auwaerter PG, Lee SH, Nousari HC, Valsamakis A, Leiferman KM, Diwan A, Adams RJ, Griffin DE (1999) Production of atypical measles in rhesus macaques: evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody. Nat Med 5:629–634
Polack FP, Lee SH, Permar S, Manyara E, Nousari HC, Jeng Y, Mustafa F, Valsamakis A, Adams RJ, Robinson HL, Griffin D (2000) Successful DNA immunization against measles: neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles. Nat Med 6:776–781
Polack FP, Hoffman SJ, Moss WJ, Griffin DE (2002) Altered synthesis of interleukin-12 and type 1 and type 2 cytokines in rhesus macaques during measles and atypical measles. J Infect Dis 185:13–19
Polack FP, Hoffman SJ, Crujeiras G, Griffin DE (2003a) A role for nonprotective complement-fixing antibodies with low avidity for measles virus in atypical measles. Nat Med 9:1209–1213
Polack FP, Hoffman SJ, Moss WJ, Griffin DE (2003b) Differential effects of priming with DNA vaccines encoding the hemagglutinin and/or fusion proteins on cytokine responses after measles virus challenge. J Infect Dis 187:1794–1800
Potkay S, Ganaway JR, Rogers NG, Kinard R (1966) An epizootic of measles in a colony of rhesus monkeys ( Macaca mulatta ). Am J Vet Res 27:331–334
Premenko-Lanier M, Rota PA, Rhodes G, Verhoeven D, Barouch DH, Lerche NW, Letvin NL, Bellini WJ, McChesney MB (2003) DNA vaccination of infants in the presence of maternal antibody: a measles model in the primate. Virology 307:67–75
Premenko-Lanier M, Rota PA, Rhodes GH, Bellini WJ, McChesney MB (2004) Protection against challenge with measles virus (MV) in infant macaques by an MV DNA vaccine administered in the presence of neutralizing antibody. J Infect Dis 189:2064–2071
Pütz MM, Bouche FB, De Swart RL, Muller CP (2003) Experimental vaccines against measles in a world of changing epidemiology. Int J Parasitol 33:525–545
Remfry J (1976) A measles epizootic with 5 deaths in newly-imported rhesus monkeys ( Macaca mulatta ). Lab Anim 10:49–57
Ruat C, Caillet C, Bidaut A, Simon J, Osterhaus ADME (2008) Vaccination of macaques with adjuvanted formalin-inactivated influenza A (H5N1) vaccines: protection against H5N1 challenge without disease enhancement. J Virol 82:2565–2569
Sabin AB, Fernandez de Castro J, Flores Arechiga A, Sever JL, Madden DL, Shekarchi I (1982) Clinical trials of inhaled aerosol of human diploid and chick embryo measles vaccine. Lancet 2:604
Sakaguchi M, Yoshikawa Y, Yamanouchi K, Sata T, Nagashima K, Takeda K (1986) Growth of measles virus in epithelial and lymphoid tissues of cynomolgus monkeys. Microbiol Immunol 30:1067–1073
Samb B, Aaby P, Whittle HC, Coll-Seck AM, Rahman S, Bennett J, Markowitz L, Simondon F (1995) Serologic status and measles attack rates among vaccinated and unvaccinated children in rural Senegal. Pediatr Infect Dis J 14:203–209
Schneider-Schaulies S, Klagge IM, Ter Meulen V (2003) Dendritic cells and measles virus infection. Curr Top Microbiol Immunol 276:77–101
Scott GBD, Keymer IF (1975) The pathology of measles in Abyssinian colobus monkeys ( Colobus guereza ): a description of an outbreak. J Pathol 117:229–233
Sergiev PG, Ryazantseva NE, Shroit IG (1960) The dynamics of pathological processes in experimental measles in monkeys. Acta Virol 4:265–273
Sharova OK, Rozina EE, Gordienko NM, Shteinberg LSH (1984) Effect of immunosuppression on morphological changes in CNS of monkeys infected with different measles virus vaccine strains. Acta Virol 28:144–147
Stittelaar KJ, Wyatt LS, De Swart RL, Vos HW, Groen J, Van Amerongen G, Van Binnendijk RS, Rozenblatt S, Moss B, Osterhaus ADME (2000) Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies. J Virol 74:4236–4243
Stittelaar KJ, De Swart RL, Osterhaus ADME (2002a) Vaccination against measles: a neverending story. Expert Rev Vaccines 1:151–159
Stittelaar KJ, Vos HW, Van Amerongen G, Kersten GFA, Osterhaus ADME, De Swart RL (2002b) Longevity of neutralizing antibody levels in macaques vaccinated with Quil A-adjuvanted measles vaccine candidates. Vaccine 21:155–157
Takeda M, Takeuchi K, Miyajima N, Kobune F, Ami Y, Nagata N, Suzaki Y, Nagai Y, Tashiro M (2000) Recovery of pathogenic measles virus from cloned cDNA. J Virol 74:6643–6647
Takeuchi K, Miyajima N, Nagata N, Takeda M, Tashiro M (2003) Wild-type measles virus induces large syncytium formation in primary human small airway epithelial cells by a SLAM(CD150)-independent mechanism. Virus Res 94:11–16
Tauraso NM (1973) Review of recent epizootics in nonhuman primate colonies and their relation to man. Lab Anim Sci 23:201–210
Valdespino-Gomez JL, De Lourdes Garcia-Garcia M, Fernandez de Castro J, Henao-Restrepo AM, Bennett J, Sepulveda-Amor J (2006) Measles aerosol vaccination. Curr Top Microbiol Immunol 304:165–193
Van Binnendijk RS, van der Heijden RWJ, Van Amerongen G, UytdeHaag FGCM, Osterhaus ADME (1994) Viral replication and development of specific immunity in macaques after infection with different measles virus strains. J Infect Dis 170:443–448
Van Binnendijk RS, van der Heijden RWJ, Osterhaus ADME (1995) Monkeys in measles research. Curr Top Microbiol Immunol 191:135–148
Van Binnendijk RS, Poelen MCM, Van Amerongen G, De Vries P, Osterhaus ADME (1997) Protective immunity in macaques vaccinated with live attenuated, recombinant, and subunit measles vaccines in the presence of passively acquired antibodies. J Infect Dis 175:524–532
Vo n Pirquet CE (1908) Das Verhalten der kutanen Tuberkulin-reaktion während der Masern. Dtsch Med Wochenschr 34:1297–1300
Warthin AS (1931) Occurrence of numerous large giant cells in the tonsils and pharyngeal mucosa in the prodromal stage of measles. Arch Pathol 11:864–874
Welshman MD (1989) Measles in the cynomolgus monkey ( Macaca fascicularis ). Vet Rec 124:184–186
WHO (2007) Manual for the laboratory diagnosis of measles and rubella virus infection. WHO/ IVB/07.01, Geneva
Yamanouchi K, Egashira Y, Uchida N, Kodama H, Kobune F, Hayami M, Fukuda A, Shishido A (1970) Giant cell formation in lymphoid tissues of monkeys inoculated with various strains of measles virus. J Med Sci Biol 23:131–145
Yamanouchi K, Chino F, Kobune F, Kodama H, Tsuruhara T (1973) Growth of measles virus in the lymphoid tissues of monkeys. J Infect Dis 128:795–799
Zhu Y, Heath J, Collins J, Greene T, Antipa L, Rota PA, Bellini W, McChesney MB (1997) Experimental measles II. Infection and immunity in the rhesus macaque. Virology 233:85–92
Zhu Y-D, Rota P, Wyatt LS, Tamin A, Rozenblatt S, Lerche N, Moss B, Bellini W, McChesney M (2000) Evaluation of recombinant vaccinia virus – measles vaccines in infant rhesus macaques with preexisting measles antibody. Virology 276:202–213
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
de Swart, R.L. (2009). Measles Studies in the Macaque Model. In: Griffin, D.E., Oldstone, M.B.A. (eds) Measles. Current Topics in Microbiology and Immunology, vol 330. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-70617-5_3
Download citation
DOI: https://doi.org/10.1007/978-3-540-70617-5_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-70616-8
Online ISBN: 978-3-540-70617-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)